{"id":109545,"link":"https://chinadigitaltimes.net/chinese/2010/09/hpa参与东南亚地区恶性疟抗药性讨论会/","date":"2010-09-28T23:42:01Z","modified":"2010-09-28T23:42:01Z","title":"HPA参与东南亚地区恶性疟抗药性讨论会","content":"<p><p><span lang=\"EN-US\"><strong>    </strong><strong>HPA东亚讯（通讯员李佳音）</strong>  </span><span lang=\"EN-US\">8</span><span>月</span><span lang=\"EN-US\">19</span><span>日</span><span>，无国界卫生组织</span><span lang=\"EN-US\">(HPA)</span><span>接受世界卫生组织湄公河区域疟疾项目（</span><span lang=\"EN-US\">Mekong Malaria Programme</span><span>，</span><span lang=\"EN-US\">MMP</span><span>）邀请，参与了在泰国曼谷举行的关于东南亚地区（特别是缅甸及其边境地区）恶性疟抗药性的非正式讨论。</span><span lang=\"EN-US\"><br /><span>    </span></span><span>会议同时邀请了比尔盖茨基金</span><span lang=\"EN-US\">(Bill &#038; Melinda Gates Foundation)</span><span>、美国国际援助署</span><span lang=\"EN-US\">(USAID)</span><span>的疟疾项目专家</span><span lang=\"EN-US\">Thomas P. Kanyok</span><span>先生及</span><span lang=\"EN-US\">Benard L. Nahlen</span><span>先生。讨论由</span><span lang=\"EN-US\">MMP</span><span>协调官</span><span lang=\"EN-US\">Charles Delacollette</span><span>先生主持。</span><span lang=\"EN-US\"><br /></span><span>    东南亚地区（特别是缅甸及其周边）青蒿素类药物抗性的出现，引起了国际社会的关注。与会的机构，包括盖茨基金及</span><span lang=\"EN-US\">USAID</span><span>希望进行干预。当获知</span><span lang=\"EN-US\">HPA</span><span>全球基金第六轮项目在中缅边境的工作后，盖茨基金及</span><span lang=\"EN-US\">USAID</span><span>专家纷纷肯定了</span><span lang=\"EN-US\">HPA</span><span>的工作，并期待在不远的将来携手控制抗药性的蔓延。</span><span lang=\"EN-US\"></span></p></p>\n","author":138,"categories":[1],"tags":[14483,8771]}